Vermont H 23: An act relating to administering stem cell products not approved by the U.S. Food and Drug Administration

Status: Read First Time and referred to the Committee on Health Care (as of 2021-01-07)

State: Vermont · Session: 2021-2022 · Bill: H 23

Sponsors: George Till

View Vermont H 23 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.